Explore tweets tagged as #cscc
Can We Spare Surgery and Radiation for Some CSCC Patients? - Andrea Boutros (@boutrosand). #Cancer #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology #CSCC
0
1
1
2025.7.29 Cadence, America’s chip design giant, funneled sensitive EDA tools to a CCP military academy tied to China’s hypersonic weapons and AI warfare. From 2015–2021, it bypassed export controls using shell companies like Phytium and CSCC—fueling the PLA’s rise. Now facing
5
316
266
Road to Nationals starts here:.Date: Sep 6th-7th.Location: Las Vegas , NV.Streaming Platforms: TBA. Appreciative to anyone everyone whose has shown support
2
4
5
ملف مرجعي شامل يساعد في تطبيق ضوابط الهيئة الوطنية للأمن السيبراني .(ECC - CSCC - DCC - OSMACC - TCC - CCC-T).ويحتوي على جميع ما يلزم من الضوابط، إرشادات التنفيذ، والمخرجات المتوقعة. ()
2
9
198
Cadence, America’s chip design giant, funneled sensitive EDA tools to a CCP military academy tied to China’s hypersonic weapons and AI warfare. From 2015–2021, it bypassed export controls using shell companies like Phytium and CSCC—fueling the PLA’s rise. Now facing $140M in
1
41
29
Action shot of lap 1…I had a great start and gained 3 places 🤩.@Brands_Hatch Indy always gives us exciting racing 👌🏻#CSCC #Elise
1
0
3
It’s @Brands_Hatch this w/end with @CSCCRacing for Brands Britannia. We’re racing on the Indy circuit & it’s all streamed live on the club’s Facebook page and YouTube channel. Most of the CSCC series are in action plus the @MorganChalleng4. 🚗💨🏁🏆🎤🎥
1
1
8
0
0
2
Cemiplimab post surgery and radiation provides a meaningful reduction in recurrence in high-risk cSCC!!.
Original Article: Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma (C-POST phase 3 trial) #Oncology #DermTwitter
0
3
8
🎥 VIDEO: Dr. Omid Hamid discusses the C-POST trial & adjuvant Libtayo in high-risk CSCC. ✔ Reduces recurrence.✔ Guides immunotherapy.✔ Elevates derm role in oncology. Watch → #CSCC #Libtayo #Cemiplimab #CPOSTTrial #Dermatology #SkinCancerCare.
0
0
0
You in casual wear vs you dressed up.
6
9
330
Couldn’t be more excited for Dr Cath Bennett 🥳winner of @MOGA_ORG ASM Young Oncologist orals for her work on the extended FU of 🇦🇺 EMPOWER-CSCC-1 . 5Y OS 60% for advanced cSCC w cemiplimab! 👏👏👏phenomenal result! . Interesting retreatment data too . @PeterMacCC @PeterMacRes
0
1
19
Here is the paper of the p3 trial on using Regeneron PD1 inhibitor (Cemiplimab) as adjuvant therapy to treat High-Risk Cutaneous Squamous-Cell Carcinoma. So there are some t-cells in tumor microenvironment for CSCC. The problem is that they cannot recognize cancer cells because
0
2
23
Ain’t been this annoyed since since Elizabeth Keen , but this dude right here 🤬
0
0
2